Rashes Flashcards

1
Q

what joint problem is associated with psoriasis

A

psoriatic arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe the causes of psoriasis

A

multifactoral= genetic + environment (stress, drugs, infection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

where are the most common sites to be affects by psoriasis

A

extensors (elbow, knee), scalp, sacrum, hands, feet, trunk, nails

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the koebner phenomenon

A

when psoriasis develops in area of skin trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is auspitz sign

A

removal of surface scale reveals tiny bleeding points (dilated capillaries in elongated dermal papillae(rete ridges))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is palmoplantar pustular

A

psoriasis type on feet/palms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

name a rare type of widespread psoriasis

A

erythrodermic or widespread pustular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

name 4 features of psoriatic nail disease

A

oncholysis (lifting of plate from bed)

nail pitting

dystrophy

subungal hyperkeratosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the biomarkers for psoriasis

A

raised markers for systemic inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name 6 co-morbidities of psoriasis

A

psoriatic arthritis, metabolic syndrome (obesity, hypertension, diabetes, lipid abnomralities), crohns disease, cancer, depression, uveitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why is life expectancy shorter in psoriasis patients

A

3x increased cardiovascular risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the topical therapies for psoriasis

A

vitamin D analogues (calcipotriol)

coal tar

dithranol

steroid ointments (beware rebound flare)

EMOLLIENTS (reduce hyperkeratosis, ant inflammatory, soften scales)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are treatments for psoriasis that doesn’t respond to topical treatment

A

phototherapy (narrowband UVB and PUVA)

systemic treatments

  • immunosupression (methotrexate, cyclosporin)
  • immune modulation (targeted biological agents)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the initial management for acne vulgaris

A

bezoly peroxide (keratolytic, antibac)

topical retinoid (Vit A derivatives- dry skin)

topical antibiotic (antibac and anti inflam)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the treatment for people with acne vulgaris who dont respond to topical treatment

A

add oral antibiotics (e.g. lymecycline/ doxycycline)
to
topical reinoid or benzoly peroxide

or
combined oral contraceptive in combo with topical agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when referred to hospital for acne what might a patient be prescribes

A

oral isotretinoin (systemic retinoid- usually cause flare before improvement, congenital defects)

17
Q

are people genetically susceptible to acne

18
Q

what are comedones

A

open (blackhead) and closed (whitehead)

19
Q

what are the secondary features of acne vulgaris

20
Q

describe the grading of acne

A

mild- scattered papules and pustules

moderate- numerous papules, pustules and mild atropic scarring

severe- cysts, nodules, significant scarring

21
Q

what is acne excoriae

A

picking spots, ruptures cysts deeply, increases risk of scarring

22
Q

describe the presentation of acne rosacea

A

age 30-60
nose, chin, cheeks and forehead

papules, pustules, erythema NO COMEDONES

prominent facial flushing exacerbated by change in temp, alcohol and spicy food

enlarged/ unshapely nose (rhinophyma)

conjuctivitis/ gritty eyes

23
Q

what cause it thought to be associated with acne rosacea

A

demodex mite

24
Q

how do you manage acne rosacea (plus telangiectasia and rhinophyma)

A

reduce aggravating factors (sun, avoid topical steroids)

topical
-metronidazole/ ivermectin (to reduce mite)

oral therapy

  • long term tertacycline
  • isotretinoin low dose if severe

for telangiectasia- vascular laser

for rhinophyma- surgery/ laser shaving

25
what are lichenoid eruptions classified by
damage and infiltration between the epidermis and dermis
26
describe the presentation of lichen planus
violaceous (pink/purple) flat topped shiny papules typically affects wrists, forearms, shins and skin levels wickams striae- fine lace like pattern on surface of papules and buccal mucosa v itchy
27
how is lichen planus
treat symptomatically- topical steroids/ oral steroids if extensive
28
how can you differentiate between bullous disorders
bullous pemphigoiD- split is Deeper, through Dej pemphiguS- split more Superficial, intra-epidermal
29
what is nikolsky's sign
when the top layers of the skin slip away from the lower layers when slightly rubbed indicates plane of cleavage within the epidermis
30
describe the presentation of bullous pemphigoid
elderly patients localised to one area or widespread on the trunk and proximal limbs large tense bullae on normal skin on erythematous base blisters burst to leave erosions non scarring itchy erythematous plaques and papules may be presenting feature nikolsky sign NEGATIVE
31
describe the presentation of pemphigus vulgaris
scalp, face, axillae, groins flaccid vesicles/ bullae- thin roofed lesions rupture to leave raw areas nikolsky sign positive mucosal involvement very common (eyes, genitals)
32
which bullous disorder has high mortality if not treated
pemphigus
33
how do you treat bullous disorders
chronic self limiting course systemic steroids immunosuppressants in pemphigoid tetracycline antibiotics (increased risk of infection) topicals - emmolients - topical steroids - topical antisepsis/ hygiene measures
34
what investigations can be done to distinguish between bullous disorders
skin biopsy with direct immunofluorescence indirect immunofluorescence